TrialClinical drug investigation2010

Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.

Gavin R Graff et al.PubMed ↗Publisher ↗

No numbers read from the abstract.